Type
1.
Assis BPN, Chaves AT, Lage DP, Cardoso MM, Freitas CS, Pereira IAG, et al. Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins. Tuberculosis (Edinburgh, Scotland). 2024;147.
Type
1.
Obi A, Varma A, Zhou L, Kasago I, Niedt G, Svidzinski C. Pseudokebnorization of leprosy: A unique phenomenon from mpox virus coinfection. JAAD case reports [Internet]. 2024;47:35-7. Available from: https://www.jaadcasereports.org/action/showPdf?pii=S2352-5126%2824%2900016-X
Type
1.
Prakoeswa FRS, Haningtyas N, Dewi LM, Handoko EJ, Azenta MT, Ilyas MF. The role of CXCL10 as a biomarker for immunological response among patients with leprosy: a systematic literature review. PeerJ [Internet]. 2024;12:1-24. Available from: https://peerj.com/articles/17170.pdf
Type
1.
Wardhani RK, Harini M, Anestherita F, Ramadhani FN. Backward logistic regression analysis of the determinants of the hand function among patients with leprosy: A cross-sectional study. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia [Internet]. 2024;19:1-8. Available from: https://e-mfp.org/wp-content/uploads/19.20.pdf
Type
1.
Sinha S, Haq MA, Ahmad R, Banik S, Kumar S, Haque M. Unmasking the Hidden Burden: A Delayed Diagnosis of Leprosy Patients With Grade 2 Disability and Its Effects on the Healthcare System in Bangladesh. Cureus [Internet]. 2024;16(4). Available from: https://www.cureus.com/articles/249573-unmasking-the-hidden-burden-a-delayed-diagnosis-of-leprosy-patients-with-grade-2-disability-and-its-effects-on-the-healthcare-system-in-bangladesh#!/
Type
1.
Ramírez-Perea N, Moran-Castaño C, Perez-Molina JA. Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?. Pneumonia (Nathan Qld.) [Internet]. 2024;16(1):1-3. Available from: https://pneumonia.biomedcentral.com/counter/pdf/10.1186/s41479-024-00127-x.pdf
Type
1.
Shen L, Ding J, Wang Y, Fan W, Feng X, Liu K, et al. Spatial-temporal trends in leprosy burden and its associations with socioeconomic and physical geographic factors: results from the Global Burden of Disease Study 2019. Public health. 2024;230:172-8.
Type
1.
Kolahi S, Ghadakchi L, Sarmadian AJ, Azimi H, Jafarpour M, Khalaji A. Challenging in leprosy relapse with antiphospholipid syndrome diagnosis: A case report. Clinical case reports [Internet]. 2024;12(4):1-6. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.8705
Type
1.
Udo S, Ogbu PS, Tsaku PA, Tukur A, NewMarch A. An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria. International health [Internet]. 2024;16(Supplement_1):i52-i59. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i52/7636815?login=false
Type
1.
Mora JAU, Angarita PD. Leprosy in Colombia: A look from life experience. International health [Internet]. 2024;16(Supplement_1):i9-i11. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i9/7636801?login=false